296 related articles for article (PubMed ID: 16416399)
1. Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes.
Patin E; Barreiro LB; Sabeti PC; Austerlitz F; Luca F; Sajantila A; Behar DM; Semino O; Sakuntabhai A; Guiso N; Gicquel B; McElreavey K; Harding RM; Heyer E; Quintana-Murci L
Am J Hum Genet; 2006 Mar; 78(3):423-36. PubMed ID: 16416399
[TBL] [Abstract][Full Text] [Related]
2. Population genetic diversity of the NAT2 gene supports a role of acetylation in human adaptation to farming in Central Asia.
Magalon H; Patin E; Austerlitz F; Hegay T; Aldashev A; Quintana-Murci L; Heyer E
Eur J Hum Genet; 2008 Feb; 16(2):243-51. PubMed ID: 18043717
[TBL] [Abstract][Full Text] [Related]
3. Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes.
Leggett CS; Doll MA; States JC; Hein DW
Arch Toxicol; 2021 Jan; 95(1):311-319. PubMed ID: 33136180
[TBL] [Abstract][Full Text] [Related]
4. N-acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergy.
Westphal GA; Reich K; Schulz TG; Neumann C; Hallier E; Schnuch A
Br J Dermatol; 2000 Jun; 142(6):1121-7. PubMed ID: 10848734
[TBL] [Abstract][Full Text] [Related]
5. A homogenizing process of selection has maintained an "ultra-slow" acetylation NAT2 variant in humans.
Patillon B; Luisi P; Poloni ES; Boukouvala S; Darlu P; Genin E; Sabbagh A
Hum Biol; 2014; 86(3):185-214. PubMed ID: 25836746
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
7. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
8. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.
Walraven JM; Doll MA; Hein DW
J Pharmacol Exp Ther; 2006 Oct; 319(1):369-75. PubMed ID: 16829624
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.
Hein DW
Mutat Res; 2002 Sep; 506-507():65-77. PubMed ID: 12351146
[TBL] [Abstract][Full Text] [Related]
12. N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer.
Demokan S; Suoglu Y; Gözeler M; Demir D; Dalay N
Mol Biol Rep; 2010 Oct; 37(7):3217-26. PubMed ID: 19898993
[TBL] [Abstract][Full Text] [Related]
13. Functional variability of rhesus macaque (Macaca mulatta) NAT2 gene for drug-metabolising arylamine N-acetyltransferase 2.
Boukouvala S; Drakomathioulaki N; Papanikolaou G; Tsirka T; Veyssière C; Sabbagh A; Crouau-Roy B; Fakis G
Biochem Pharmacol; 2021 Jun; 188():114545. PubMed ID: 33831395
[TBL] [Abstract][Full Text] [Related]
14. Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation.
Hein DW; Zhang X; Doll MA
Toxicol Lett; 2018 Feb; 283():100-105. PubMed ID: 29180287
[TBL] [Abstract][Full Text] [Related]
15. Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cells.
Wise JTF; Salazar-González RA; Habil MR; Doll MA; Hein DW
Toxicol Appl Pharmacol; 2022 May; 442():115993. PubMed ID: 35353990
[TBL] [Abstract][Full Text] [Related]
16. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A
Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012
[TBL] [Abstract][Full Text] [Related]
17. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2.
Smelt VA; Mardon HJ; Sim E
Pharmacol Toxicol; 1998 Oct; 83(4):149-57. PubMed ID: 9820875
[TBL] [Abstract][Full Text] [Related]
18. Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyl-transferase encoding genes of the Syrian hamster.
Ferguson RJ; Doll MA; Rustan TD; Hein DW
Pharmacogenetics; 1996 Feb; 6(1):55-66. PubMed ID: 8845861
[TBL] [Abstract][Full Text] [Related]
19. Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamster.
Hein DW; Doll MA; Xiao GH; Feng Y
Pharmacogenetics; 2003 Mar; 13(3):159-67. PubMed ID: 12618593
[TBL] [Abstract][Full Text] [Related]
20. Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey.
Sabbagh A; Darlu P; Crouau-Roy B; Poloni ES
PLoS One; 2011 Apr; 6(4):e18507. PubMed ID: 21494681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
